Gene Therapy Using Hepatocyte Growth Factor Expressing Adenovirus Improves Skin Flap Survival in a Rat Model
Dong-Kyun RAH; In-Sik YUN; Chae-Ok YUN; Sae-Bin LEE; Won-Jai LEE.
Journal of Korean Medical Science
; : S228-S236, 2014.
Artículo en Inglés | WPRIM | ID: wpr-191056
Documentos relacionados
Gene therapy using hepatocyte growth factor expressing adenovirus improves skin flap survival in a rat model.
Low-dose simultaneous delivery of adenovirus encoding hepatocyte growth factor and vascular endothelial growth factor in dogs enhances liver proliferation without systemic growth factor elevation.
Accelerated adhesion of grafted skin by laser-induced stress wave-based gene transfer of hepatocyte growth factor.
Synergistic effects of autologous cell and hepatocyte growth factor gene therapy for neovascularization in a murine model of hindlimb ischemia.
Effects of different scar types on flap viability in a skin flap model: an experimental study.
Overexpression of indoleamine dioxygenase in rat liver allografts using a high-efficiency adeno-associated virus vector does not prevent acute rejection.
Adenoviral vectors infect B lymphocytes in vivo.
Safety and Efficacy of Ex Vivo Donor Lung Adenoviral IL-10 Gene Therapy in a Large Animal Lung Transplant Survival Model.
Elimination of donor CD47 protects against vascularized allograft rejection in mice.
Concomitant Reconstruction of Multiple Scalp Defects With One Rotational Flap.